Pharmaceutical Qui Tam Whistleblower Lawsuits: Billions Of Dollars At Stake

Qui Tam, or whistleblower, lawsuits have increased dramatically over the past few years’ especially in the pharmaceutical industry for off-label drugs uses not approved by the U.S. Food & Drug Administration (FDA). Whistleblowers, also known as relators, have collected billions of dollars for reporting fraudulent activity against the government’ and billions more are at stake.

→ Read More

Whistleblower Lawsuits: Astronomical Settlement Figures Are Common

Qui Tam lawsuits that are filed on behalf of the government for fraudulent activity are generally complex in nature and usually take a bit longer to resolve than other lawsuits due to the time it takes to sort through government contracts and regulations. While a handful of cases go to trial, most settle’ and for astronomical figures.

→ Read More

Qui Tam Lawsuits Involve Any Form of Fraud Against the Government

Qui Tam, or whistleblower, lawsuits have a long history. In fact, President Lincoln signed the False Claims Act into law in 1863. While most people associate whistleblower lawsuits with military contractors, numerous amendments to the Act allow for suits for any form of fraud committed on the government by a government contractor.

→ Read More

Largest U.S. Whistleblower Lawsuit in U.S. History Settled for $1.4 Billion

Global pharmaceutical giant Eli Lilly has agreed to pay approximately $1.4 billion in fines, damages and penalties to settle several whistleblower lawsuits. The lawsuits alleged that the company defrauded Medicare, Medicaid and other health care programs in connection with Zyprexa, its anti-psychotic drug. It is thought to be largest whistleblower, or Qui Tam, settlement in U.S. history.

→ Read More